425: Kimberly-Clark Reports Strong 2025, Eyes Kenvue Synergy

Kimberly-Clark delivered robust Q4 and full-year 2025 results, driven by its 'Powering Care' strategy, and remains confident in its pending Kenvue acquisition to create a global health and wellness leader.

Summary

• Kimberly-Clark reported 2% organic growth in Q4 2025, with 3% volume-plus-mix growth, despite a slowdown in global weighted average category growth to approximately 60 basis points.
• Full-year 2025 saw approximately 2% volume-led organic growth, marking the second consecutive year of broad-based volume-plus-mix growth.
• The 'Powering Care' strategy, launched two years ago, has driven strong results through commercial, cost, and organizational capability enhancements, innovation, and portfolio pivot.
• The company is transforming into a pure-play personal care company, having sold its Brazilian Tissue Operations and PPE business, and exited approximately $650 million of private label business.
• A joint venture with Suzano for International Family Care & Professional (49% stake) is expected to close mid-2026.
• The pending acquisition of Kenvue is anticipated to create a $32 billion pure-play, global health & wellness leader with 10 iconic billion-dollar brands.
• Kenvue acquisition is expected to generate $2.1 billion of annual synergies (net of reinvestment), including $1.9 billion in cost synergies within the first three years, and achieve solid EPS accretion in year two following close.
• Gross productivity savings reached 6.2% of adjusted COGS for FY25, peaking at 7.2% in Q4, exceeding the expected range of 5-6%.
• Adjusted Free Cash Flow for 2025 was $1.9 billion, largely in line with previous estimates.
• North America delivered a third consecutive year of positive volume-plus-mix led growth, with Kleenex achieving its highest share in 9 years.
• International Personal Care (IPC) business showed strong volume-plus-mix led organic growth, accelerating to mid-single-digit levels in Q4, with weighted average share gains of +50 basis points in focus markets for the year.

Sentiment

Score: 8

Explanation: The filing conveys a strong sense of confidence and positive momentum, highlighting successful execution of the 'Powering Care' strategy, robust financial performance, and strategic clarity regarding the Kenvue acquisition and portfolio transformation. While acknowledging external challenges, the overall tone is optimistic about future growth and value creation.

Positives

• Achieved 2% organic growth in Q4 2025 and approximately 2% volume-led organic growth for the full year 2025.
• Delivered 3% volume-plus-mix growth in Q4 2025, marking the eighth consecutive quarter of solid performance.
• Gross productivity savings reached an industry-leading 6.2% of adjusted COGS for FY25 and 7.2% for Q4, exceeding targets.
• Expanded Adjusted Operating Profit margins by 180 basis points in the past two years, on pace to reach 18-20% before the end of the decade.
• Returned Gross Margins to pre-pandemic levels in H2 2023 and expanded further, with strong visibility to achieving at least 40% before the end of the decade.
• Improved cash conversion cycle from 6 days in 2021 to approximately -10 days at the close of 2025.
• Maintained leverage below 2.0x Net Debt-to-EBITDA ratio, consistent with a single-A credit rating.
• International Personal Care (IPC) business delivered strong volume-plus-mix led organic growth for the year, accelerating to mid-single-digit levels in Q4, with all IPC Focus Markets showing volume-led organic growth in the quarter.
• Gained approximately 50 basis points of weighted average share in IPC focus markets for the year.
• North America achieved a third consecutive year of positive volume-plus-mix led growth, with Kleenex reaching its highest share in 9 years.
• Successful innovation launches, with 78% of FY25 volume and mix led growth attributable to innovations from the last three years.
• Strong shareholder support for the Kenvue acquisition, with over 90% of votes in favor through January 28, 2026.
• Ranked #2 overall CPG by customers in the 2025 Advantage Survey of retailers, out of the top 80 or so CPG companies, having previously been ranked #1 for three consecutive years.

Negatives

• Global weighted average category growth slowed to approximately 60 basis points in Q4 2025 from a run-rate of approximately 2% during the prior 9 months.
• Experienced an uptick in competitive promotion activity in the third and fourth quarters.
• Operating Profit in North America was essentially flat year-over-year, absorbing a 330 basis points headwind from divestitures and business exits.
• Pressure on consumers and a focus on value are expected to persist in 2026.
• The 2026 outlook for Adjusted EPS attributable to total Kimberly-Clark is expected to be in line with 2025 levels on a constant currency basis, partly offset by a reduction in Income from Discontinued Operations.

Risks

• The anticipated benefits and synergies of the Kenvue mergers may not be realized when expected or at all.
• The terms and scope of the expected financing in connection with the Kenvue mergers may prove to be less favorable than currently expected.
• The Kenvue mergers may not be completed in a timely manner or at all.
• Risk of litigation related to the Kenvue mergers.
• Delays or failure to complete the proposed International Family Care & Professional (IFP) transaction.
• Incurrence of significant transaction and separation costs related to the IFP transaction.
• Adverse market reactions, regulatory or legal challenges, and operational disruptions related to the IFP transaction.
• Inability to realize the anticipated benefits of the 2024 Transformation Initiative, including disruptions to business or operations or related to any delays in implementation.
• Impacts from the war in Ukraine, including responses of consumers, customers, suppliers, and sanctions.
• Government trade or similar regulatory actions, including current and potential trade and tariff actions affecting operating countries and resulting negative impacts on supply chain, commodity costs, and consumer spending.
• Pandemics, epidemics, fluctuations in foreign currency exchange rates, and the prices and availability of raw materials.
• Supply chain disruptions, disruptions in the capital and credit markets, and counterparty defaults.
• Failure to realize the expected benefits or synergies from acquisition and disposition activity.
• Impairment of goodwill and intangible assets and projections of operating results affecting impairment testing.
• Changes in customer preferences, severe weather conditions, regional instabilities and hostilities.
• Potential competitive pressures on selling prices for products, energy costs, and general economic and political conditions.
• Ability to maintain key customer relationships.

Future Outlook

Kimberly-Clark projects 2026 Organic Growth to be in-line to ahead of category growth (estimated at ~2%), with mid-to-high single-digit constant-currency Adjusted Operating Profit growth. Adjusted EPS from Continuing Operations is expected to see double-digit constant-currency growth, while Adjusted EPS attributable to total Kimberly-Clark is anticipated to be flat constant-currency, partly due to reduced contribution from discontinued operations. Capital investments are set to increase to approximately $1.3 billion. Beyond 2026, assuming a year-end close of the Kenvue acquisition, the company expects to deliver on-algorithm Adjusted EPS growth in the mid-to-high single-digit range on a 2-year CAGR from 2026 to 2028, with significant accretion in 2028 as synergies take hold.

Management Comments

• "Our 2025 results, and the momentum we’ve built in the first two years of Powering Care, reflect the enhanced strength and resilience of our business." Mike Hsu, Chairman and CEO
• "Acquiring Kenvue is a powerful next step in our transformation, that we believe will enhance the momentum we’re delivering across Kimberly-Clark." Mike Hsu, Chairman and CEO
• "We expect to generate $2.1 billion of annual synergies from the transaction, net of reinvestment, including about $1.9 billion of cost synergies, targeted within the first three years after close." Mike Hsu, Chairman and CEO
• "Its still very early, but I am very energized by the opportunities we see, and even more confident in our ability to deliver, and eventually surpass, the synergies we’ve previously outlined." Russ Torres, President and COO
• "We strongly believe our strategy will serve Kimberly-Clark well and lead to value creation – both today and over the long-term." Russ Torres, President and COO
• "Our transformation is gaining momentum. We’ve addressed the volatility of the past through discipline, process and portfolio actions. And we’re well-equipped to continue performing while we undertake a generational transformation of our company." Nelson Urdaneta, CFO
• "We expect both the pending International Family Care & Professional business transaction, and the Kenvue acquisition to improve our ability to deliver the consistent, top-tier growth we laid out with our long-term financial algorithm." Nelson Urdaneta, CFO
• "I expect the vote [for Kenvue] to reflect the very positive feedback we've heard from our investors. And so through yesterday, pretty good chunk of shareholders have already voted. And it's well in, you know, in excess of 90% in favor." Mike Hsu, Chairman and CEO (Q&A)
• "We haven't seen anything that would change our view on the potential of this combination [Kenvue]." Russ Torres, President and COO (Q&A)

Industry Context

Kimberly-Clark's strategic pivot towards higher-growth, higher-margin personal care categories and its focus on innovation-led growth positions it well within the consumer packaged goods (CPG) industry. The company acknowledges a challenging environment with pressure on consumers and retailers, and geopolitical volatility, which aligns with broader industry trends. Its emphasis on premiumization while also delivering value propositions across price tiers reflects a common strategy among CPG leaders to navigate diverse consumer spending habits. The Kenvue acquisition is a significant move to create a scaled health and wellness leader, potentially reshaping the competitive landscape in that segment of the CPG market.

Comparison to Industry Standards

• Delivered industry-leading gross productivity at 6.2% of adjusted COGS for FY25, peaking at 7.2% for Q4, exceeding the high end of its expected range of 5-6%.
• Was one of the first in the industry to successfully pivot to volume-plus-mix led organic growth coming off the last inflationary super cycle.
• Was one of the first of its peers to return Gross Margins to pre-pandemic levels in the second half of 2023.
• Ranked as the #2 overall CPG by customers in the 2025 Advantage Survey of retailers, out of the top 80 or so CPG companies, having previously been ranked #1 for three consecutive years.
• Achieved #1 ranking in key sub-categories, including reputation and relationship with one of its most important customers, in the Advantage Survey.

Legal Proceedings

• Risk of litigation related to the Kenvue mergers is mentioned in forward-looking statements.

Stakeholder Impact

• **Shareholders**: Expected significant value creation through the Kenvue acquisition, including $2.1 billion in synergies and EPS accretion by year two. Strong cash flow generation and commitment to growing dividends.
• **Consumers**: Enhanced focus on consumer-centric innovation, superior value propositions, and crushing stigma in intimate categories, aiming to improve lives and provide better products.
• **Employees**: Integration Management Office (IMO) staffed with leaders from both Kimberly-Clark and Kenvue, indicating potential organizational restructuring and new opportunities/challenges.
• **Customers/Retailers**: Strengthened partnerships and execution excellence, as evidenced by high rankings in the Advantage Survey, aiming to deliver outstanding value and partnership.
• **Suppliers**: Supply chain optimization and digital procurement capabilities to drive efficiency and transparency.

Next Steps

• Live question-and-answer session with analysts for Q4 2025 earnings.
• Presentation at the CAGNY conference next month to detail growth initiatives, innovation pipeline, and commercial engine.
• Completion of filing all applicable international jurisdictions for Kenvue acquisition by early February 2026.
• Expected mid-year 2026 close of the International Family Care & Professional joint venture transaction with Suzano.
• Expected second half 2026 closing of the Kenvue acquisition.
• Integration milestones for Kenvue acquisition, with 40% of cost synergies expected in year 1, 40% in year 2, and 20% in year 3 post-closing.

Key Dates

Recommendation

Kimberly-Clark's Q4 and full-year 2025 results demonstrate strong operational momentum, driven by its 'Powering Care' strategy, which has successfully pivoted the portfolio towards higher-growth, higher-margin personal care categories. The company is delivering industry-leading productivity and expanding margins ahead of expectations. The pending acquisition of Kenvue is a transformative move, expected to create a global health and wellness leader with substantial synergies ($2.1 billion) and EPS accretion by year two. Management's conservative modeling for Kenvue's integration and strong shareholder support for the deal further de-risk the transaction. The clear path to sustained profitable growth, robust cash flow generation, and strategic repositioning makes Kimberly-Clark a compelling 'strong buy' for long-term investors seeking exposure to a resilient, innovation-driven consumer staple company with significant growth catalysts.

Keywords

Kimberly-Clark, Kenvue acquisition, Q4 2025 earnings, Powering Care strategy, Personal Care, Consumer Health, Synergies, Organic Growth, Productivity, SEC filing, Financial results, Corporate transformation, International Family Care & Professional JV, Diapers, Adult Care, Feminine Care